Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1999
08/24/1999US5942253 Prolonged release of GM-CSF
08/24/1999US5942252 Increasing the bioavailability of a drug by administering an effective amount of microcapsules to animal, the microcapsules comprising active agent encapsulated in a biocompatible and biodegradable excipient
08/24/1999US5942245 Application of SOD in liposomes
08/24/1999US5942243 Mucoadhesive compositions for administration of biologically active agents to animal tissue
08/24/1999US5942242 Medicaments for nasal administration
08/24/1999US5942236 Potential vaccine for use against lyme disease to induce a protective immune response in humans by administrating a purified immunogenic outer surface lipoprotein of micelle form
08/24/1999US5942235 Exogenous dna encoding an antigenic determinant of a pathogen; recombinant viruses and gene products are useful for cancer therapy
08/24/1999US5942234 Hepatitis C virus asialoglycoproteins
08/24/1999US5942230 Composition of immunotoxins and retinoids and use thereof
08/24/1999US5942229 Method for prolonged suppression of humoral immune response to a thymus-dependent antigen therapeutic agent
08/24/1999US5942227 Treating type 2 diabetes mellitus or insulin resistance patient
08/24/1999US5942225 Comprising the stem cells and one or more bioactive factors for inducing differentiation of them into a single particular lineage, e.g. bone, muscle, tendon, ligament, connective tissue cells
08/24/1999US5942224 Comprising human interferon-alpha derived from ball-1 cells and either cat serum albumin, gelatin or maltose; small dosages administered by mouth or injection
08/24/1999US5942223 Antiviral therapy using ovine or bovine interferon-tau
08/24/1999US5942222 Administering cytokines macrophage inflammatory proteins (mip-1 and 2) capable of enhancing myelopoietic colony stimulating factor, binding to heparin, and inducing local inflammation having polymorphonuclear cell infiltration
08/24/1999US5942221 Recombinant primate granulocyte macrophage-colony stimulating factor
08/24/1999US5942220 Inhibitor of cytokine activity and applications thereof
08/24/1999US5941868 Localized intravascular delivery of growth factors for promotion of angiogenesis
08/24/1999US5941240 Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume
08/24/1999CA2248972A1 Novel compounds
08/24/1999CA2212548C Use of carbazole compounds for the treatment of congestive heart failure
08/24/1999CA2141475C Type 1 and type p fimbriae-adhesins isolated from novel e. coli strains, process for their preparation and uses thereof
08/24/1999CA1340716C Inhibition of eucaryotic pathogens and neoplasms and stimulation of fibroblasts and lymphocytes with lytic peptides
08/24/1999CA1340715C Bovine interleukin-1b
08/20/1999CA2261183A1 Adenoviral transfer vector for the gene transport of a dna sequence
08/20/1999CA2249653A1 Novel compounds
08/19/1999WO1999041614A2 Method for detecting intimin producing microorganisms
08/19/1999WO1999041610A1 Serological diagnosis of chagas' disease
08/19/1999WO1999041412A1 A novel npg-1 gene that is differentially expressed in prostate tumors
08/19/1999WO1999041407A1 Method for developing a pharmaceutical active ingredient
08/19/1999WO1999041404A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
08/19/1999WO1999041397A1 Anti-viral vectors
08/19/1999WO1999041387A2 Prostate-associated serine protease
08/19/1999WO1999041382A2 A novel interleukin-3 and uses thereof
08/19/1999WO1999041377A1 Novel cystine knot protein and materials and methods for making it
08/19/1999WO1999041376A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins
08/19/1999WO1999041375A2 Human receptor proteins
08/19/1999WO1999041374A2 Human short-chain tnf-receptor family protein
08/19/1999WO1999041373A2 Human transport-associated molecules
08/19/1999WO1999041372A1 Potassium channel polypeptide
08/19/1999WO1999041370A1 Cea/nca-based differentiation cancer therapy
08/19/1999WO1999041363A1 Podocalyxin like sialomucins having selectin ligand activity
08/19/1999WO1999041361A1 Protease-based dietary supplementation for decreasing recovery time from soft-tissue injury
08/19/1999WO1999041359A1 Modified adenovirus containing a fiber replacement protein
08/19/1999WO1999041355A2 Hiv chemokines
08/19/1999WO1999041286A1 DERIVATISED ANTIBODIES WITH EXPOSED CARBOHYDRATE CHAINS CAPABLE OF BINDING TO IMMOBILISED IgG
08/19/1999WO1999041285A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
08/19/1999WO1999041284A1 Secreted proteins and polynucleotides encoding them
08/19/1999WO1999041283A1 Pf4 fragments and pharmaceutical compositions containing same
08/19/1999WO1999041282A1 Therapeutic uses of keratinocyte growth factor-2
08/19/1999WO1999041279A2 Methods and compositions comprising the use of blocked b-amyloid peptide
08/19/1999WO1999041278A1 Cyclic peptide inhibitors of pla2
08/19/1999WO1999041277A1 Novel acetamide derivative and use thereof
08/19/1999WO1999041276A1 β-SHEET MIMETICS AND METHODS RELATING TO THE USE THEREOF
08/19/1999WO1999041271A1 High affinity nucleic acid ligands of complement system proteins
08/19/1999WO1999041270A1 Compositions and methods for the inhibition of muc-5 mucin gene expression
08/19/1999WO1999041251A1 Antagonists of gonadotropin releasing hormone
08/19/1999WO1999041247A1 TREATMENT OF MULTIPLE SCLEROSIS USING COP-1 AND Th2-ENHANCING CYTOKINES
08/19/1999WO1999040946A2 Methods and compositions for modulating leptin activity
08/19/1999WO1999040945A2 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
08/19/1999WO1999040940A1 Ligands of the cd47 antigen, agents binding the ligands of the cd47 antigen and uses thereof
08/19/1999WO1999040939A1 Method for the prevention and treatment of a type i hypersensitivity disorder
08/19/1999WO1999040935A1 Novel preventives/remedies for immunopathy
08/19/1999WO1999040933A1 Use of hyaluronidase to reduce viscoelastic related increases in intraocular pressure
08/19/1999WO1999040932A1 Mixed micellar pharmaceutical delivery system and method of preparation
08/19/1999WO1999040931A1 Cyclic dipeptides and azetidinone compounds and their use in treating cns injury and neurodegenerative disorders
08/19/1999WO1999040930A1 Specific inhibitors of nfat activation by calcineurin and their use in treating immune-related diseases
08/19/1999WO1999040929A1 Methods to potentiate cancer therapies
08/19/1999WO1999040928A1 Novel mixed amylin activity compounds
08/19/1999WO1999040926A1 Agents and methods for protection, treatment and repair of connective tissue
08/19/1999WO1999040881A2 Specific antibodies against mammary tumor-associated mucin, method for production and use
08/19/1999WO1999040788A1 Inotropic and diuretic effects of exendin and glp-1
08/19/1999WO1999033998A3 Regulatory dna sequences of the human catalytic telomerase sub-unit gene, diagnostic and therapeutic use thereof
08/19/1999WO1999033985A3 C1F150/hTAFII150 IS NECESSARY FOR CELL CYCLE PROGRESSION
08/19/1999WO1999031125B1 Wound healing compositions
08/19/1999WO1999030670A3 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
08/19/1999WO1999025844A9 Mammalian cell death preventing kinase, dpk
08/19/1999WO1999025815A3 Nucleic acids involved in the responder phenotype and applications thereof
08/19/1999WO1999024076A3 Salicylate derivatized therapeutic and diagnostic agents
08/19/1999WO1999024074A3 Novel conjugates of opioids and endogenous carriers
08/19/1999WO1999024058A3 Neuronal uses of bmp-11
08/19/1999WO1999023108A9 Inducible phosphofructokinase and the warburg effect
08/19/1999WO1999020753A3 Peptide bond formation using nucleic acid catalysts
08/19/1999WO1999004266A3 Interactions of atm, atr or dna-pk with p53
08/19/1999WO1998055110A3 NEW USES FOR COMPOUNDS WHICH REDUCE c-jun GENE EXPRESSION
08/19/1999WO1998030590A9 Analogs of parathyroid hormone
08/19/1999DE19802377A1 Verwendung von Inhibitoren für die Behandlung von RTK-Überfunktions-bedingten Störungen, insbesondere von Krebs Use of inhibitors for the treatment of RTK function-related disorders, particularly cancer
08/19/1999CA2321277A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg
08/19/1999CA2321146A1 Novel acetamide derivative and use thereof
08/19/1999CA2321136A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
08/19/1999CA2321135A1 Modified adenovirus containing a fiber replacement protein
08/19/1999CA2321105A1 Human short-chain tnf-receptor family protein
08/19/1999CA2321097A1 Anti-viral vectors
08/19/1999CA2320753A1 Method for detecting intimin producing microorganisms
08/19/1999CA2320618A1 Secreted proteins and polynucleotides encoding them
08/19/1999CA2320515A1 Therapeutic uses of keratinocyte growth factor-2
08/19/1999CA2320512A1 Novel preventives/remedies for immunopathy
08/19/1999CA2320427A1 Human receptor proteins
08/19/1999CA2320424A1 Human transport-associated molecules
08/19/1999CA2320391A1 Novel cystine knot protein and materials and methods for making it
1 ... 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 ... 3163